Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Thursday, February 5, 2015

Africa: Cultural practices may be driving hepatitis C infection rates in West Africa

Reports that suggest high rates of serologic false positives and low levels of viremia have contributed to uncertainty regarding the burden of active hepatitis C infection.

 A lack of knowledge surrounding the transmission and progression of hepatitis C virus infection in West African countries may be contributing to the spread of the disease, results of a study published in Clinical Infectious Diseases indicate.

"This is a small study conducted at a blood bank in a teaching hospital in Ghana," explained Jennifer Layden, MD, PhD, of Loyola University in Chicago, Ill., in a press release. “The goal is to further understand whom is affected by hepatitis C and to identify specific next steps in intervention and prevention.”

More than 180 million people have hepatitis C. In developed countries, hepatitis C infection is often transmitted through intravenous (IV) drug use, but this may not be the case in West Africa, noted the investigators.


Read more...

No comments:

Post a Comment